title: Fludarabine, mitoxantrone and dexamethasone as first-line treatment for T-cell large granular lymphocyte leukemia.
authors.forename: E
authors.initials: E
authors.lastname: Tse
authors.forename: J C W
authors.initials: JC
authors.lastname: Chan
authors.forename: A
authors.initials: A
authors.lastname: Pang
authors.forename: W-Y
authors.initials: WY
authors.lastname: Au
authors.forename: A Y H
authors.initials: AY
authors.lastname: Leung
authors.forename: C C K
authors.initials: CC
authors.lastname: Lam
authors.forename: Y-L
authors.initials: YL
authors.lastname: Kwong
mesh_terms: D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003907:Dexamethasone / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D015458:Leukemia, T-Cell / Q000188:drug therapy*; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy*; D008297:Male; D008495:Medical Oncology / Q000379:methods; D008942:Mitoxantrone / Q000008:administration & dosage*; D016896:Treatment Outcome; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives*
chemical_list: D003907:Dexamethasone; D008942:Mitoxantrone; D014740:Vidarabine; C024352:fludarabine